2019 MASCC/ISOO Annual Meeting Presentations

June 21-23, 2019  •  San Francisco, CA USA


  For sessions available with audio, CLICK HERE


The following presentations have been converted to PDF to optimize file size.

WORKSHOP PRESENTATIONS >> See Workshops 2019 for descriptions and presentations.
Jump to Plenary Sessions
Jump to Parallel Sessions
Jump to Young Investigators Parallel Session
Jump to ISOO Parallel Sessions
Jump to Joint Sessions
Jump to Meet the Expert Sessions
Jump to Supported Symposia
Jump to Study Group Presentations


Plenary Session 1: Digital Health: Science Fact, Not Science Fiction
Chair: Ian Olver, Australia
Digital Health and Oncology: Towards Connected Cancer Care  - Sangeeta Agarawal, USA
Overview of Artificial Intelligence (AI) - Alice Landis-McGrath, USA
Overview of Virtual Reality, Augmented Reality and Wearables  - David Rhew, USA

Plenary Session 2: New Treatments, New Toxicities
Chair: Rajesh Lalla, USA
Patient-Reported Outcomes (PRO-CTCAE) - Ethan Basch, USA
CAR T-Cell Therapy Toxicity Lori Muffly, USA
New Radiotherapy Modalities Sue Yom, USA

Plenary Session 3: Sexual Health: Treatment Strategies
Chair: Hope Rugo, USA
Sexual Problems in Male Cancer Patients: An Overview John Mulhall, USA
Sexual Problems in Female Cancer Patients Tami Rowen, USA
Oncofertility Francesca Duncan, USA


Parallel Session 01: Emerging Themes
Chairs: Florian Scotte, France, Tamura Kazuo, Japan
Microbiome: How It Matters - Rachel Gibson, Australia
The Truth Is Out There! Untangling the Evidence Around the Anticancer Effects of Anticoagulants - S. Noble, United Kingdom
The Consequences of Erectile Dysfunction and Other Sexual Changes After Prostate Cancer: A Comparison of Gay/Bisexual and Heterosexual Men - J. Ussher, Australia
Enteric Nervous System Toxicity Underlying Gastrointestinal Side-effects of Chemotherapy: Mechanisms and Potential Treatments  - K. Nurgali, Australia

Parallel Session 02: Implementing the MASCC Cancer-Related Fatigue Treatment Guidelines for the Younger and Geriatric Population
Chairs: Karen Mustian, USA, Stephen Samuel, India
Implementing Psychosocial and Integrative Therapies for the Treatment of Cancer-Related Fatigue - Karen Mustian, USA
Strategies to Implement Exercise as a Treatment Modality to Manage Cancer-Related Fatigue - Stephen Samuel, India
Strategies to Implement Pharmacological and Nutraceutical Interventions for the Management of Cancer-Related Fatigue - Sriram Yennu, USA
Higher Levels of Acute and Chronic Stress Are Associated with Worse Morning and Evening Fatigue Profiles in Oncology Outpatients Receiving Chemotherapy - K. Kober, USA
The Promotion of Exercise Oncology as a Standard Part of Clinical Practice - K. Wonders, USA

Parallel Session 03: Sexual Health in Head and Neck Cancer
Chairs: Cherry Estilo, USA, Deborah Saunders, Canada
Head and Neck Cancer and Sexuality in the Era of HPV: Common Patient Questions and Answers - Eleni Rettig, USA
Body Image and Sexuality Research in Head and Neck Cancer - Bethany Rhoten, USA
Approaches to Interventions and Management Strategies of Sexual Dysfunction in Head and Neck Cancer - Karl Torbicki, Canada
Understanding Suicide Rate, Risk Factors and Trends Among Head and Neck Cancer Survivors - Nosayaba Osazuwa-Peters, USA

Parallel Session 04: Digital Health in Action
Chairs: Declan Walsh, USA, Anna Boltong, Australia
Teleoncology - Ian Olver, Australia
Symptom Assessment of Cancer Patients - Christine Miaskowski, USA
Digital Health: The Challenges - Jo Armes, United Kingdom
Efficacy of an E-health Self-Management Application ‘Oncokompas’ to Support Cancer Survivors to Obtain Optimal Supportive Care – Results of a Randomized Controlled Trial - A. Van Der Hout, The Netherlands
Does AI Increase Closeness or Decrease It? Clinician VS Patient Viewpoint - S. Agarawal, USA

Parallel Session 05: When Carers Need Care: Burnout in Cancer Healthcare Providers and Caregivers
Chairs: Bogda Koczwara, Australia, Jason Freedman, USA
Juggling Career and Family While Avoiding Burnout: The Challenge of Pediatric Oncology - Andrea Orsey, USA
Burnout in Palliative Care: When You Are a Survivor and Carer - Redwing Keyssar, USA
Why Physician Wellness Matters and Strategies to Reduce Burnout - Lidia Schapira, USA
The Perceptions of Parental Illness Questionnaire-cancer: An Instrument to Assess Illness Perceptions Among Young People Who Have a Parent With Cance r - C. Fletcher, Australia
Implementing Psycho-social Distress Screening and Intervention Program in Pediatric Oncology - A. Mohamed, USA

Parallel Session 06: Mucositis Management: Systematic Review - One Goal, Various Approaches
Chairs: Paolo Bossi, Italy, Karis Cheng, Singapore
WALT: The Case of PBM for Mucositis - Praveen Arany, USA
Blautia Luti Regulates Gastrointestinal Toxicity in Cancer Patients Receiving Standard Dose Chemotherapy - Hanna Wardill, The Netherlands

Parallel Session 07: Updates in Hemostasis
Chairs: Carmen Escalante, USA, Paz Fernández Ortega, Spain
Empowering Cancer Patients for Non-pharmacological Primary Prevention and Early Recognition of Cancer-Associated Venous Thromboembolism (VTE): The Empatic-CP Survey - C. Font, Spain
The Safety and Efficacy of Oral Edoxaban Administration Without Initial Heparin Therapy for Venous Thromboembolism in Cancer Patients - R. Kogawa, Japan
Laboratory Biomarkers Predictive of VTE Risk - Howard Liebman, USA
Digital Apps to Manage Anticoagulants and Control Symptoms - Judy Phillips, USA
Anticoagulation for Venous Thromboembolism in Special Populations (Obesity, Underweight, Pregnancy, Renal Failure) - Cristhiam Rojas Hernandez, USA

Parallel Session 08: New Strategies for Managing Neurotoxic Treatment-Related Complications
Chairs: Maryam Lustberg, USA, Katherine Peters, USA
Emerging Targets and Pathways in Chemotherapy-Associated Cognitive Impairment - Alex Chan, Singapore
Novel Therapeutics for Chemotherapy-Induced Neuropathy - Charles Loprinzi, USA
A Randomized Assessor-blinded Wait-list Controlled Trial to Assess the Effectiveness and Cost-effectiveness of Acupuncture in the Management of Chemotherapy-induced Peripheral Neuropathy - A. Molasiotis, Hong Kong S.A.R.
Neuromodulation as a Treatment for Chemotherapy-Induced Neuropathy - Sarah Prinsloo, USA
Prevention of Oxaliplatin-induced Peripheral Neuropathy (OIPN): Randomized Placebo-Controlled Trial Results Investigating Efficacy and Safety of a Recombinant Soluble Human Thrombomodulin (ART-123) - Y. Uchida, Japan

Parallel Session 09: The Changing Face of Febrile Neutropenia
Chair: Bernardo L. Rapoport, South Africa
Febrile Neutropenia: Symptoms, Diagnosis, Treatment, and Best Practice - Bernardo L. Rapoport, South Africa
Treatment of Neutropenia in High-Risk Patients Including Acute Leukemia and Bone Marrow Transplants - Tim Cooksley, United Kingdom
Positive Effects of Trilaciclib on Patient Myelosuppression-related Symptoms and Functioning: Results From Three Phase 2 Randomized, Double-blind, Placebo-controlled Small Cell Lung Cancer Trials - S. Morris, USA

Parallel Session 10: Let's Talk About Sex
Chairs: Andrea Orsey, USA, Jason Freedman, USA
Sexual and Reproductive Health of Adolescent and Young Adult Patients - Natasha Frederick, USA
Sexual Health and Preparedness in Survivors of Childhood Cancer: The Child-to-Adult TransitionSexual Dysfunction in Adolescent and Young Adult Patients and Survivors - Leslie Schover, USA
Needs for Information and Support About Sexuality-related Issues of Adolescent and Young Adult Cancer Patients: Room for Improvement? - L.F. Albers, The Netherlands
The Veil of Cancer Symptoms in Children: Symptoms We Know About Are Not the Same as the Ones That Cause Distress - P. Yates, School of Nursing

Parallel Session 11: Complications of Immunotherapy
Chairs: Bernardo L. Rapoport, South Africa, Mario Lacouture, USA
Intro: Complications of Immunotherapy - Mario Lacouture, USA
Basic Mechanisms - Bernardo L. Rapoport, South Africa
Overview of Recommendations on Immune-Related Adverse Events - Michael Postow, USA
Emergencies - Tim Cooksley, United Kingdom
GI Toxicities - Michael Dougan, USA
Rheumatological Toxicities - Anne Bass, USA
Renal Toxicities - Jean Klastersky, Belgium

Parallel Session 12: Opioids for Cancer Pain - Keep Calm and Carry On?
Chairs: Gregory Crawford, Australia, David Hui, USA
Opioids for Cancer Pain - What Is the Evidence? - Mellar Davis, USA
Opioid Addiction in Cancer Patients: Prevention and Management - Declan Walsh, USA
Management of Opioid-Induced Bowel Dysfunction - Andrew Davies, United Kingdom
An Investigation of the Sensitivity of the Rome IV Criteria for Opioid-induced Constipation - C. Leach, United Kingdom
The Effect of Abdominal Massage in Managing Opioid-induced Constipation - D. Yildirim, Turkey

Parallel Session 13: Cancer Survivorship Across the Life Cycle
Chairs: Lidia Schapira, USA, Bogda Koczwara, Australia
Pediatric and Adolescent and Young Adults (AYA) Cancer Survivors - Faith Gibson, United Kingdom
Adult Cancer Survivors - Michael Jefford, Australia
GeriOnc Cancer Survivors - William Dale, USA
Symptom Clusters in Cancer Survivors - M. Mazor, USA
Employment and Financial Challenges Faced by Adolescent and Young Adult (AYA) Cancer Survivors: A Qualitative Study - C.J. Tan, Singapore

Parallel Session 14: Cancer Survivorship (Debate): Every Cancer Survivor Must Have a Written Survivorship Care Plan
Chair: Lidia Schapira, USA
Every Cancer Survivor Must Have a Written Cancer Survivorship Care Plan - Bogda Koczwara, Australia
Enrique Soto-Perez-de-Celis, Mexico
Deborah Mayer, USA
Bogda Koczwara, Australia
Michael Jefford , Australia
Faith Gibson , United Kingdom
William Dale , USA

Parallel Session 15: The ABCs of Palliative Cancer Care in the Digital Age: Analytics, Best Practices, and Criteria for Referral
Chairs: Egidio Del Fabbro, USA, David Hui, USA
Advances in Anorexia-Cachexia Assessments: The Role of Artificial Intelligence and Smartphones - Egidio Del Fabbro, USA
Best Practices: Optimizing Supportive Care Interventions in Electronic Medical Records - Janet Abrahm, USA
Criteria for Referral: Standardizing Palliative Care Referral with Automatic Triggers - David Hui, USA
Phase 2 Trial of Symptom Screening With Targeted Early Palliative Care (STEP) for Patients With Advanced Cancer - Zimmermann, Canada
Early and Systematic Integration of Palliative Care in Multidisciplinary Oncology Care: A Randomized Controlled Trial - G. Vanbutsele, Belgium

Parallel Session 16: Sexual Health: A Multi-dimensional Problem
Chairs: Penelope Schofield, Australia, Debra Barton, USA
Sexual Problems in Cancer Patients: An Introduction - Debra Barton, USA
Overcoming the Barriers - Shari Goldfarb, USA
Sexual Issues in Partners of Cancer Patients - J. Ussher, Australia
Discussing Sexuality in Cancer Care: What Information Do Patients Need? - L.F. Albers, The Netherlands
Predictors of Women’s Self-efficacy to Communicate With Their Partner About Sex and Intimacy After Cancer Treatment - E. Arthur, USA

Parallel Session 17: The Changing Face of Palliative Care
Chairs: Gregory Crawford, Australia, Eric Roeland, USA
What Do We Mean by Palliative Care? - Mellar Davis, USA
The Evidence Base for "Early" Palliative Care - Eric Roeland, USA
How Should Palliative Care Services Integrate into Oncology Services? - David Hui, USA
The Enhanced Supportive Care Programme: Improving Access to Supportive and Palliative Care in the Cancer Centre - R. Berman, United Kingdom
The Effectiveness and Cost-effectiveness of Hospital Palliative Care for Adults With Advanced Disease: A Systematic Review - S. Bajwah, United Kingdom

Parallel Session 18: Controversial Issues in Antiemetic Control
Chairs: Rita Wickham, USA, Mitsue Saito, Japan
Introduction - Rita Wickham, USA
Are There Strategies to Improve Antiemetic Access? - Mitsue Saito, Japan
Olanzapine, Do the Guidelines Have It Right? - David Warr, Canada
Pharmacogenomics in the Management of Chemotherapy-Induced Nausea and Vomiting - Sandip Mukhopadhyay, India
Alterations in Patterns of Gene Expression and Perturbed Pathways in the Gut-brain Axis Are Associated With Chemotherapy-induced Nausea - K. Singh, USA
US Physician Concordance with Update to Guidelines Classifying Carboplatin AUC ≥ 4 as Highly Emetogenic Chemotherapy (HEC) - R. Navari, USA

Parallel Session 19: Hot Topics in Palliative Care
Chairs: Carla Ida Ripamonti, Italy, Simon Noble, United Kingdom
VTE in Advanced Cancer - Simon Noble, United Kingdom
De-prescribing in Palliative Care - Jo Thompson, United Kingdom
Management of "Terminal Agitation": Evidence Versus Pragmatism - Gregory Crawford, Australia
How did the Introduction of Medical Assistance in Dying Impacted Palliative Care in Canada? - A. Al-Awamer, Canada
Integrating Medical Cannabis Within a Quaternary Oncology Center: The Cannabis Pilot Project at the McGill University Health Centre - A. Dr Vigano, Canada

Parallel Session 20: Psychosocial and Functional Consequences of Skeletal Toxicity
Chairs: Lidia Schapira, USA, Beatrice Edwards, USA
Epidemiology of Bone Health Issues in Patients with Cancer - Beatrice Edwards, USA
Functional and Psychosocial Consequences of Fractures - Nelson Watts, USA
Clinical Guidelines for the Management of Bone Health in Patients with Cancer - Matti Aapro, Switzerland
Pain Flare-Effect Prophylaxis With Corticosteroids on Bone Radiotherapy Treatment: A Systematic Review - Fabregat Franco, Spain


Chairs: Joanne Bowen, Australia, Joel Epstein, USA
Reflections of an Experienced Investigator - Joel Epstein, USA
Gabapentin Mitigates Neuropsychiatric Symptoms in Patients Undergoing Concurrent Chemo-Radiation for Head and Neck Cancer: Interim Results from a Randomized Trial - D. Smith, USA
Fixed-Dose 7.5 mg Rasburicase Is Safe and Cost-Effective in Preventing Tumour Lysis Syndrome in Adult Haematology Patients at University College London Hospitals (UCLH) NHS Trust - R. Burgoyne, United Kingdom
Symptoms Predictive of Overall Quality of Life Using the Edmonton Symptom Assessment Scale in Breast Cancer Patients Receiving Radiotherapy - S. Chow, Canada
Association of Frailty With Emotional Health of Older Patients With Advanced Cancer: A University of Rochester NCI Community Oncology Research Program Geriatric Assessment Trial - N. Gilmore, USA
Treatment-Related Mortality in Children with Acute Lymphoblastic Leukemia in a Low-Middle-Income Countr y - R. Ul-Ain, Pakistan


ISOO Parallel Session 1: Smoking Cessation
Chair: Siri Beier-Jensen, Denmark
Myth Busters of Clinical Tobacco Intervention in the Oncology Setting and Professional Perceptions - Deborah Saunders, Canada
Cancer Patient Awareness and Attitudes about Tobacco Cessation - Lawson Eng, Canada

ISOO Parallel Session 2: Lymphedema and Fibrosis in Head and Neck Cancer Survivors: Biology and Clinical Manifestations
Chair: Barbara Murphy, USA
Lymphedema in the Head and Neck Cancer Population: Incidence, Impact and Measurement - Jie Deng, USA

ISOO Parallel Session 3: Dysphagia in Head and Neck Cancer Patients: Evaluation and Management
Chair: Deborah Saunders, Canada
Acute and Long-Term Swallow Dysfunction in Head and Neck Cancer Patients: Evaluation and Management - Katherine Hutcheson, USA - ONLINE Presentation
Case Presentation with Panel Discussion
Panelists: Katherine Hutcheson, USA, John Wu, Canada, Barbara Murphy, USA, Deborah Hawkins, USA


ISNCC / MASCC Joint Session: Multidisciplinary Team (MDT) Working
Chairs: Christine Miaskowski, USA, Patsy Yates, Australia2
Cancer MDTs: Do They Make a Difference? - Jo Thompson, United Kingdom
Dealing with Conflict within MDTs - Penelope Schofield, Australia
Empowering Patients and Carers - Patsy Yates, Australia

EONS / MASCC / ONS Joint Session: How Patients Feel Really Matters - Challenges and Opportunities for Oncology Nursing in a Digital Era
Chairs: Annie Young, United Kingdom, Andreas Charalambous, Cyprus, Pamela Ginex, USA
Effective Patient-Provider Communication - Pamela Ginex, USA
Outpatient Experiences with Web-Based Applications to Monitor Their Symptoms (EONS 1) - Wendy Oldenmenger, The Netherlands
Personalizing Virtual Environments through Immersive Virtual Reality: The Patient Perspective on Achieving the Goal of Patient-Centeredness (EONS 2) - Andreas Charalambous, Cyprus
Using Patient-Reported Outcomes for Patient Decision-Making (ONS) - Donna Berry, USA
Using a Community-based, Nurse-led Cancer Information and Support Line to Deliver Phone-based Supportive Care Interventions: An Australian Experience (MASCC) - Katherine Lane, Australia

AFSOS / MASCC / NICSO Joint Session: Developing Supportive Care in Cancer: A European Perspective
Chairs: Carla Ida Ripamonti, Italy, Florian Scotte, France
Dedicated Supportive Care Units (SCUs): An Italian Model - Carla Ida Ripamonti, Italy
Dedicated SCUs: A French Perspective - Florian Scotte, France
Supportive Care Teams Outside the Hospital: A French Model - Mario Di Palma, France
Models of Education in Supportive Care - Andrea Antonuzzo, Italy
NICSO Research Program - Paolo Bossi, Italy
AFSOS Research Program - Ivan Krakowski, France

ISOPP / MASCC Joint Session: Biosimilars
Chairs: Matti Aapro, Switzerland, Hope Rugo, USA
Biosimilars in Supportive Care - Emma Foreman, United Kingdom
Current Guidelines on the Use of Biosimilars - Harbans Dhillon, Malaysia
Biosimilars in Oncology - Hope Rugo, USA

JASCC / MASCC Joint Session: Cancer Survivorship in Adolescents and Young Adults (AYA)
Chairs: Mitsue Saito, Japan, Margaret Fitch, Canada
Overview of the Issues - Michael Feuerstein, USA
The Impact of Cancer on Adolescent and Young Adult Survivors’ Work-Related Issues - Miyako Takahashi, Japan
Follow-up of AYA Cancer Survivors - Margaret Fitch, Canada
Ongoing Trials: AYA Cancer Survivors in Asia - Alex Chan, Singapore

MASCC / SIOG Joint Session: Managing the Oldest and Frailest Oncology Patients
Chairs: Annie Young, United Kingdom, Christopher Steer, Australia
Geriatric Assessment in Day-to-Day Practice - Rana Jin, Canada
Optimizing Quality of Life - William Dale, USA
Geriatric Oncology in Low and Middle-Income Countries - Enrique Soto-Perez-de-Celis, Mexico
Association of Polypharmacy and Potentially Inappropriate Medications With Physical Function in Older Patients With Cancer Receiving Chemotherapy: A University of Rochester Nationwide Geriatric Assessment Study - M. Mohamed, USA
Older Cancer Survivors Have a Lower Symptom Burden - B. Quintanilla, USA


Meet the Experts: Writing for Supportive Care in Cancer
Chairs: Fred Ashbury, Canada, Ian Olver, Australia, Jørn Herrstedt, Denmark
Developing and Submitting Supportive Care Practice Guidelines to MASCC For Approval/Endorsement
Writing for Peer-Reviewed Publication

Meet the Experts: Using Social Media
Chairs: Hannah Wardill, The Netherlands, Ysabella Van Sebille, Australia
Social Media: MASCC's New Strategic Focus to Enhance the Provision of Supportive Care in Cancer - Ysabella Van Sebille, Australia
Social Media in Healthcare: How to Communicate With Impact  - Marie Ennis O'Connor, Ireland
Lessons Learned: How #GeriOnc and ASCO Are Leading the Way in Social Media Engagement - Enrique Soto-Perez-de-Celis, Mexico
“How Many Likes Did We Get?”: The Use of Social Media in Cancer NGOs: The Cancer Council Experience - Katherine Lane, Australia 

Supported Symposia

Scalp Cooling - Supported Symposium Organized by Paxman and Dignitana
Chairs: Frances Boyle, Australia, Hope Rugo, USA
Impact of Alopecia on Quality of Life - Frances Boyle, Australia
Cooling for Prevention of Chemotherapy-induced Alopecia - The Evidence - Hope Rugo, USA
Scalp Cooling for Prevention of Chemotherapy-induced Alopecia - The "Real World" Experience - Corina van den Hurk, The Netherlands
​Endocrine Therapy-Induced Alopecia - Mario Lacouture, USA
Patient's Perspective - Jaime Zapata, USA  


Antiemetics - Agenda

Bone & Musculoskeletal - Agenda


Geriatrics - Agenda Study Group Survey

Mucositis - Agenda

Palliative Care - Agenda


Survivorship - Agenda